Explore mGluR2/GRM2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2017]
| Target ID |
GM-T62820
|
| Target Name |
mGluR2/GRM2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
2912
|
| Gene ID |
100052178 (Equus caballus), 101098611 (Felis catus), 108068 (Mus musculus), 24415 (Rattus norvegicus) 2912 (Homo sapiens), 484751 (Canis lupus familiaris), 519904 (Bos taurus), 700214 (Macaca mulatta)
|
| Target Alternative Names |
4930441L02Rik,GLUR2,GPRC1B,GRM2,Gprc1b,Grm2,MGLUR2,Metabotropic glutamate receptor 2,mGlu2,mGluR2,mGluR7
|
| Uniprot Accession |
Q14BI2,P31421,Q14416
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Glutamatergic synapse, Cocaine addiction
|
| Gene Ensembl |
ENSECAG00000009276, ENSMUSG00000023192, ENSG00000164082, ENSCAFG00845018876, ENSBTAG00000001067, ENSMMUG00000012005
|
| Target Classification |
GPCR
|
mGluR2/GRM2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo2912 | Pre-made Human GRM2/GLUR2/mGlu2 siRNA oligo Duplex | 2912 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo24415 | Pre-made Rat Grm2/mGlu2 siRNA oligo Duplex | 24415 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo108068 | Pre-made Mouse Grm2/Gprc1b/mGluR2 siRNA oligo Duplex | 108068 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo700214 | Pre-made Cynomolgus/Rhesus macaque GRM2 siRNA oligo Duplex | 700214 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101098611 | Pre-made Cat/Feline GRM2 siRNA oligo Duplex | 101098611 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo484751 | Pre-made Dog/Canine GRM2 siRNA oligo Duplex | 484751 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo519904 | Pre-made Bovines/Cattle GRM2 siRNA oligo Duplex | 519904 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100052178 | Pre-made Equine/Horse GRM2 siRNA oligo Duplex | 100052178 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
mGluR2/GRM2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T62820-Ab | Human | Anti-Human mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T62820-Ab | Rat | Anti-Rat mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T62820-Ab | Mouse | Anti-Mouse mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T62820-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T62820-Ab | Cat/Feline | Anti-Cat/Feline mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T62820-Ab | Dog/Canine | Anti-Dog/Canine mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T62820-Ab | Bovines/Cattle | Anti-Bovines/Cattle mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T62820-Ab | Equine/Horse | Anti-Equine/Horse mGluR2/GRM2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
mGluR2/GRM2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T62820-Ag | Human | Human mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T62820-Ag | Rat | Rat mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T62820-Ag | Mouse | Mouse mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T62820-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T62820-Ag | Cat/Feline | Cat/Feline mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T62820-Ag | Dog/Canine | Dog/Canine mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T62820-Ag | Bovines/Cattle | Bovines/Cattle mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T62820-Ag | Equine/Horse | Equine/Horse mGluR2/GRM2 VLP (virus-like particle) | HEK293 | Products Developing |